People with celiac disease are significantly more likely to develop bone and joint problems — and new research suggests the connection runs deeper than diet alone. A study published in Clinical Rheumatology analyzed data from hundreds of thousands of UK Biobank participants and found that celiac disease is associated with six distinct musculoskeletal conditions, with partly shared genetic roots explaining some of that overlap.
This matters to me as a celiac parent. My son’s condition is always framed as a digestive disease — something in the gut that gluten triggers. But the evidence keeps pointing outward: to the bones, joints, and immune system. Studies like this one reinforce that what happens in the intestine doesn’t stay there.
What This Means for You
The study identified six musculoskeletal conditions that occurred significantly more often in people with celiac disease: osteoporosis (bone loss), osteoarthritis (joint cartilage breakdown), rheumatoid arthritis (autoimmune joint inflammation), systemic lupus erythematosus (an autoimmune disease affecting multiple organs), spondylosis (spinal degeneration), and enthesopathies and synovial disorders (conditions affecting the sites where tendons attach to bone and the lining of joints).
The numbers carry real weight. People with celiac disease were 68% more likely to go on to develop musculoskeletal conditions over follow-up, compared to those without celiac. The relationship also worked in reverse: people with a higher burden of musculoskeletal disease were more than twice as likely to have celiac disease. That bidirectional pattern — each condition raising risk for the other — is a signal worth paying attention to.
For families managing a celiac diagnosis, this adds to the already strong case for routine bone density monitoring. Osteoporosis has long been recognized as a celiac complication, partly because intestinal damage impairs calcium and vitamin D absorption. But this study finds the link goes beyond malabsorption; the genetic analyses suggest osteoporosis and celiac share underlying biological pathways. We have covered the bone health side of this picture before — including research on hip geometry and bone mineral density in celiac patients and long-term denosumab treatment for celiac patients with osteoporosis at high fracture risk. This new study adds population-scale epidemiological and genetic confirmation to what those smaller studies showed.
The rheumatoid arthritis and lupus findings are perhaps more surprising. These are autoimmune diseases, and the genetic overlap with celiac disease suggests they share immune dysregulation pathways — not just downstream nutritional consequences. For patients presenting with unexplained joint inflammation or autoimmune symptoms, this study adds to the argument that undiagnosed celiac disease should be on the differential.
Key Takeaways
- Celiac disease was associated with six musculoskeletal conditions in a large UK Biobank cohort: osteoporosis, osteoarthritis, rheumatoid arthritis, lupus, spondylosis, and joint/tendon attachment disorders.
- People with celiac disease were 68% more likely to develop musculoskeletal conditions; people with high musculoskeletal disease burden were more than twice as likely to have celiac disease.
- Genetic analyses found shared biological architecture between celiac and osteoporosis, and between celiac and rheumatoid arthritis — meaning diet and malabsorption don’t fully explain the connection.
- This study does not establish that one condition causes the other, and the researchers explicitly say it does not define a new screening strategy.
- Celiac patients and their care teams should be aware of bone and joint health as part of ongoing management, not just gut symptom control.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Study Design and Data Source
The researchers drew on the UK Biobank, a large prospective cohort of around 500,000 UK adults with detailed health records and genetic data. They ran two types of analyses. The first was a prospective cohort analysis: they identified people with celiac disease at baseline and tracked who later developed musculoskeletal conditions, and vice versa. The second was a cross-sectional analysis: they looked at whether people with more musculoskeletal conditions were more likely to already have celiac disease at the same time point.
To estimate risk, they used Cox proportional hazards models — a statistical method for measuring how much a given condition speeds up the time-to-event (in this case, developing a second condition). For the cross-sectional analysis, they used logistic regression to assess whether cumulative musculoskeletal burden was associated with celiac odds.
All results were adjusted using FDR correction (false discovery rate correction), a statistical safeguard against false positives that is important when testing many conditions at once, as this study did across 24 musculoskeletal conditions.
The Six Conditions and Risk Estimates
After FDR correction, six conditions showed statistically significant associations with celiac disease: osteoporosis, osteoarthritis, rheumatoid arthritis (autoimmune destruction of joint lining), systemic lupus erythematosus or SLE (a systemic autoimmune disease), spondylosis (degenerative disease of the spine’s vertebrae and discs), and enthesopathies and synovial disorders (conditions affecting the sites where tendons or ligaments attach to bone, and disorders of the synovium — the membrane lining joints).
For overall musculoskeletal burden rather than individual conditions, the hazard ratios were striking. With celiac as the exposure — meaning looking at whether having celiac predicted later musculoskeletal disease — the hazard ratio was 1.68 (95% CI 1.51–1.87), a 68% elevated risk. With celiac as the outcome — looking at whether musculoskeletal burden predicted later celiac diagnosis — the hazard ratio was 2.31 (95% CI 2.12–2.51), more than doubling the risk.
The researchers also examined polygenic risk score (PRS) — a genetic score that aggregates the cumulative effect of many common genetic variants associated with a trait. Higher PRS for celiac disease and greater musculoskeletal burden were each independently associated with higher odds of prevalent celiac, reinforcing that genetic predisposition and disease burden both contribute.
Shared Genetic Architecture
To understand whether the associations reflect shared biology versus shared environmental or lifestyle factors, the team ran two genetic methods using external GWAS summary statistics (genome-wide association study data compiled from large prior studies).
The first method, linkage disequilibrium score regression (LDSC), estimates genetic correlation — how much of the genetic variation driving one condition overlaps with the genetic variation driving another. The researchers found FDR-significant positive genetic correlations between celiac disease and osteoporosis (rg = 0.307) and between celiac and rheumatoid arthritis (rg = 0.279). A genetic correlation of around 0.3 is moderate — it means roughly a third of the genetic architecture is shared, not that the conditions are the same disease. Notably, enthesopathies and synovial disorders showed no consistent genetic correlation with celiac despite the epidemiological association, which may mean those links are mediated by downstream effects of celiac (such as inflammation or malabsorption) rather than shared genetic roots.
The second method, generalized summary-data-based Mendelian randomization (GSMR), uses genetic variants as natural instruments to probe whether the relationship between two traits has a directional component — essentially, whether genes that raise risk for condition A also tend to raise risk for condition B. The researchers found several FDR-significant directional signals involving osteoporosis, rheumatoid arthritis, and lupus. They are appropriately cautious: GSMR findings in exploratory analyses require careful interpretation and do not establish causation on their own.
Spondyloarthropathy Context
The spondylosis and enthesopathy findings connect to a body of earlier research on spinal inflammatory disease in celiac patients. We previously covered frequency of spondyloarthropathy in patients with celiac disease, which examined the prevalence of inflammatory spinal and joint conditions in this population. The current study, with its population-scale cohort design, adds epidemiological weight to those earlier observations.
What the Study Does Not Show
The authors are explicit: these findings do not establish causality, and they do not define a screening strategy. The UK Biobank cohort skews older and healthier than the general population, which could limit how well the findings generalize. The study also relied on clinical records and self-report for celiac diagnosis, which may miss undiagnosed cases. Mendelian randomization results should be treated as hypothesis-generating rather than confirmatory.
What the study does show — and this is genuinely useful — is a consistent, replicated, biologically grounded pattern of co-occurrence between celiac and musculoskeletal disease, across both epidemiological and genetic methods in a very large dataset.
For families like mine, the practical takeaway is simple: celiac disease is a systemic condition, and bone and joint health belong in the monitoring conversation from the start. If your celiac care team isn’t asking about musculoskeletal symptoms, it’s worth bringing this research to them.
Related Coverage
- Frequency of Spondyloarthropathy in Patients with Celiac Disease
- Hip Geometry, Trabecular Bone Score, and Bone Mineral Density in Patients with Celiac Disease
- Long-Term Treatment with Denosumab in Patients with Celiac Disease and Osteoporosis at High Risk of Fracture
References
- Cai J, Wang M, Yao X. Associations between coeliac disease and musculoskeletal conditions: epidemiology and genetic evidence from a large-scale cohort study. Clinical Rheumatology. 2026. PubMed